These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3424863)

  • 1. Plasma protein binding of ceftriaxone.
    Popick AC; Crouthamel WG; Bekersky I
    Xenobiotica; 1987 Oct; 17(10):1139-45. PubMed ID: 3424863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat.
    Klotz U; Antonin KH; Bieck PR
    J Pharmacol Exp Ther; 1976 Oct; 199(1):67-73. PubMed ID: 789856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum protein binding of a new oral cephalosporin, CL 284,635, in various species.
    Bialer M; Tonelli AP; Kantrowitz JD; Yacobi A
    Drug Metab Dispos; 1986; 14(1):132-6. PubMed ID: 2868857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics.
    Prueksaritanont T; Gorham LM; Naue JA; Hamill TG; Askew BC; Vyas KP
    Drug Metab Dispos; 1997 Mar; 25(3):355-61. PubMed ID: 9172954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
    Steinke W; Ahr HJ; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein binding characteristics of a new bronchodilator, 1-methyl-3-propylxanthine (MPX), in different species.
    Apichartpichean R; Takagi K; Kuzuya T; Nadai M; Ohshima T; Suzuki K; Horiuchi T; Miyamoto K; Hasegawa T
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):320-3. PubMed ID: 2777419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein binding of ceftriaxone: comparison of three techniques of determination and the effect of 2-hydroxybenzoylglycine, a drug-binding inhibitor in uremia.
    Fiset C; Vallée F; LeBel M; Bergeron MG
    Ther Drug Monit; 1986; 8(4):483-9. PubMed ID: 3824437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro plasma protein binding of propafenone and protein profile in eight mammalian species.
    Puigdemont A; Arboix M; Gaspari F; Bortolotti A; Bonati M
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):435-40. PubMed ID: 2781140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of plasma and free tissue levels of ceftriaxone in rats by microdialysis.
    Kovar A; Dalla Costa T; Derendorf H
    J Pharm Sci; 1997 Jan; 86(1):52-6. PubMed ID: 9002459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species-dependent enantioselective plasma protein binding of MK-571, a potent leukotriene D4 antagonist.
    Lin JH; deLuna FA; Ulm EH; Tocco DJ
    Drug Metab Dispos; 1990; 18(4):484-7. PubMed ID: 1976072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro study of ceftriaxone binding to blood].
    Brandebourger M; Barré J; Hamberger C; Pochet I; Tillement JP
    Pathol Biol (Paris); 1986 May; 34(5):320-4. PubMed ID: 3534698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of cyclosporine. II. Blood plasma distribution and binding studies.
    Awni WM; Sawchuk RJ
    Drug Metab Dispos; 1985; 13(2):133-8. PubMed ID: 2859158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of abouthiouzine: a novel antihyperthyroid drug.
    Alkharfy KM; Khan RM; Al-Hadiya BM; Abou-Auda HS; Abou-Shaaban RR
    Biopharm Drug Dispos; 2007 Apr; 28(3):105-11. PubMed ID: 17230598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
    Zacchei AG; Weidner LL; Besselaar GH; Raftery EB
    Drug Metab Dispos; 1976; 4(4):387-401. PubMed ID: 8295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse.
    Löscher W
    J Pharmacol Exp Ther; 1978 Feb; 204(2):255-61. PubMed ID: 340640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of age and dose on the pharmacokinetics of ibuprofen in the rat.
    Satterwhite JH; Boudinot FD
    Drug Metab Dispos; 1991; 19(1):61-7. PubMed ID: 1673423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phencyclidine blood protein binding: influence of protein, pH and species.
    Owens SM; Mayersohn M; Woodworth JR
    J Pharmacol Exp Ther; 1983 Sep; 226(3):656-60. PubMed ID: 6887006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of remoxipride in different species. Species differences in metabolism.
    Widman M; Nilsson LB; Bryske B; Lundström J
    Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.